| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $0.6B | $0.7B | $0.6B | $0.4B |
| EPS (Basic) | $2.46 | $3.45 | $3.65 | $2.44 |
| EPS (Diluted) | $2.46 | $3.45 | $3.65 | $2.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $14.7B | $13.5B | $10.1B | $9.9B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | $8.4B | $7.4B | $5.2B | $5.8B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $6.2B | $6.1B | $5.0B | $4.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $-0.5B | $-2.5B | $0.5B | $0.7B |
| Investing Cash Flow | — | — | — | — |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $0.5B | $2.6B | $-0.4B | $-0.6B |